Skip to content
healthcare.dev

Dabigatran Etexilate

NDC 67877-474, Dabigatran Etexilate, capsule, coated pellets, from Ascend Laboratories, LLC.

Product NDC
67877-474
Status
Listed
Labeler
Ascend Laboratories, LLC
Dosage form
CAPSULE, COATED PELLETS
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA208040
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/67877-474 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DABIGATRAN ETEXILATE MESYLATE75 mg/1

Pharmacologic classes

Direct Thrombin Inhibitor [EPC]; Thrombin Inhibitors [MoA]

Package NDCNDC-11Package
67877-474-606787704746060 CAPSULE, COATED PELLETS in 1 BOTTLE (67877-474-60)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/3a8ec82a-c367-40dc-9302-e1896fcb05ea
  • NADAC price for package 67877047460

    GET /v1/drugs/nadac/67877047460

Use it

Look up 67877-474 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/67877-474 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 67877-474. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.